ACCOLADE INC. - COMMON STOCK

Accolade Stockholders Approve Merger Between Accolade and Transcarent

27 Mar 2025 16:05:00 By Nasdaq GlobeNewswire

Transcarent and Accolade Announce Expiration of Hart-Scott Rodino Waiting Period for Pending Merger Transaction

24 Feb 2025 17:20:27 By Nasdaq GlobeNewswire

Transcarent To Acquire Accolade

08 Jan 2025 08:30:00 By Nasdaq GlobeNewswire

Accolade to Announce Fiscal Third Quarter 2025 Financial Results

16 Dec 2024 08:00:00 By Nasdaq GlobeNewswire

Accolade To Present at Upcoming Investor Conferences

13 Nov 2024 08:00:00 By Nasdaq GlobeNewswire

Accolade Announces Results for Fiscal Second Quarter 2025

08 Oct 2024 07:00:29 By Nasdaq GlobeNewswire

Accolade to Announce Fiscal Second Quarter 2025 Financial Results

18 Sep 2024 08:00:00 By Nasdaq GlobeNewswire

Accolade To Present at Morgan Stanley 22nd Annual Global Healthcare Conference

28 Aug 2024 08:00:00 By Nasdaq GlobeNewswire

Accolade To Present at Canaccord Genuity 44th Annual Growth Conference & Private Company Showcase

07 Aug 2024 08:00:00 By Nasdaq GlobeNewswire

Accolade Announces Results for Fiscal First Quarter 2025

27 Jun 2024 16:03:21 By Nasdaq GlobeNewswire

Accolade to Announce Fiscal First Quarter 2025 Financial Results

12 Jun 2024 08:00:00 By Nasdaq GlobeNewswire

Accolade To Present at William Blair Growth Stock Conference

29 May 2024 08:00:01 By Nasdaq GlobeNewswire

Accolade Announces Results for Fiscal Fourth Quarter and Full Year 2024

25 Apr 2024 16:03:38 By Nasdaq GlobeNewswire

Accolade to Announce Fiscal Fourth Quarter 2024 Financial Results

03 Apr 2024 08:00:00 By Nasdaq GlobeNewswire

Accolade To Present at Upcoming Investor Conferences

28 Feb 2024 08:00:00 By Nasdaq GlobeNewswire

Accolade Announces Results for Fiscal Third Quarter 2024

08 Jan 2024 16:03:00 By Nasdaq GlobeNewswire

Accolade To Present at Upcoming Investor Conferences

02 Jan 2024 08:00:00 By Nasdaq GlobeNewswire

Accolade to Announce Fiscal Third Quarter 2024 Financial Results

11 Dec 2023 08:00:00 By Nasdaq GlobeNewswire

Accolade To Present at Piper Sandler 35th Annual Healthcare Conference

27 Nov 2023 08:00:05 By Nasdaq GlobeNewswire

Accolade Announces Repurchase of $76.5 Million of 0.50% Convertible Senior Notes Due 2026

16 Nov 2023 16:03:57 By Nasdaq GlobeNewswire